Search Results

The Spectris Solaris MR Injection System is a syringe-based fluid delivery system for the delivery of contrast media during computed tomography applications. It is intended to be used for the specific purpose of injecting intravenous contrast media into a patient's vascular system for diagnostic imaging. Only trained healthcare professionals are intended to operate this device.

syringe-based fluid delivery system

This document is a 510(k) premarket notification approval letter for the Medrad Spectris Solaris Injector System. It does not contain information regarding acceptance criteria, device performance studies, or details about ground truth establishment, sample sizes for training/testing, or expert qualifications.

The letter explicitly states that the FDA has reviewed the 510(k) and found the device substantially equivalent to legally marketed predicate devices. This means that the manufacturer presented evidence to the FDA demonstrating that their device is as safe and effective as a device already on the market. The FDA approves the device based on this substantial equivalence, but the approval letter itself does not include the detailed study or performance data.

Therefore, I cannot provide the requested information from the provided text. The document is an approval letter, not a study report or a summary of performance data.

Ask a specific question about this device